Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07877974Recruiting
Randomised, double-blind trial of bupivacaine in postoperative pain (2 arms), sponsored by Cairo University. Primary endpoint: Time to first postoperative analgesic request at 24 hours. Started Nov 2026; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07877974.